A special kind of genetic test that helps determine the best antidepressant for patients with…
sciencecityNovember 15, 2023
Parkinson disease is a progressive neurological disorder, with many symptoms involving motor impairments, such as…
sciencecityNovember 14, 2023
Dr. Lara Boyd, a professor in the UBC Faculty of Medicine’s department of physical therapy,…
sciencecityNovember 14, 2023
Canada is a world-leader in genomic research—the study of all of a person’s or population’s…
sciencecityNovember 13, 2023
The LUMINA trial demonstrated a very low local recurrence rate in women ≥55 years with…
sciencecityNovember 13, 2023
AbCellera today presented new data on its T-cell engager (TCE) programs in two poster presentations…
sciencecityNovember 10, 2023
It is with great excitement we congratulate Dr. Emily Bordeleau on being awarded the Killam…
sciencecityNovember 10, 2023
A Vancouver company is central to the news Monday morning that Pfizer is close to developing an effective…
eabramovichNovember 13, 2020
A new article by NMIN researchers published in the journal Nanoscale sheds light on a potential mechanism…
eabramovichNovember 12, 2020
AbCellera today announced that bamlanivimab (LY-CoV555) 700 mg, a human antibody developed through AbCellera’s collaboration…
eabramovichNovember 11, 2020
Dr. Alexander Wyatt, Assistant Professor in the Department of Urological Sciences at UBC and Senior…
eabramovichNovember 10, 2020
Two scientists recently shared the Nobel Prize for Chemistry for transforming an obscure bacterial immune…
eabramovichNovember 9, 2020
A Burnaby biotech company has enrolled and dosed its first volunteer with an oral DNA…
eabramovichNovember 6, 2020
Fresh water is unequivocally one of British Columbia (BC)’s most valuable natural resources and is…
eabramovichNovember 5, 2020
Alpha-9 Theranostics Inc.TM, a radiopharmaceutical company developing unique technology for imaging and treatment of metastatic…
eabramovichNovember 3, 2020
